バイオミメティック・デュアル・エンジン・ナノ破壊機は,細胞外マトリックスを退化させ,TAM2をハイジャックし,HCCにおける深い免疫浸透を解き放つ
Jianwei Yang1,2, Zhongsheng Xu1,2, Haiyan Lan2
1Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Small (Weinheim an der Bergstrasse, Germany)
|August 30, 2025
まとめ
この研究では,腫瘍関連ファイブロブラストとマクロファージを再プログラムすることで,肝細胞癌 (HCC) を標的とする新しいナノ医薬品であるZHL@CMを紹介しています. このアプローチにより 薬の浸透が促進され 癌に対する全身免疫反応が強化されます
科学分野:
- 生物医学工学
- ナノテクノロジー
- 癌 研究
背景:
- 肝細胞癌 (HCC) は高度に侵襲的な悪性腫瘍である.
- 腫瘍関連線維細胞 (CAF) とマクロファージ (TAM) は,HCCの侵入と免疫回避に寄与する.
- 効果的なHCC治療には,ストロマおよび免疫抵抗の克服が不可欠です.
研究 の 目的:
- HCCにおけるシネジスティックな免疫調節のためのバイオミメティックなナノ破壊器 (ZHL@CM) を設計する.
- 腫瘍の微小環境がもたらす 物理的な障壁を克服するために
- CAFとTAMを再プログラムして 抗腫瘍免疫を強化する
主な方法:
- ロサルタン (LST) とラディックスヘディサリポリサカリド (HPS) をゼオリチスイミダゾラート (ZIF) フレームワークで封入する.
- ZIF構造をマクロファージ膜でカモフラージュして ZHL@CMを作ります
- 酸性腫瘍の微小環境における LST と Zn2+ の放出を調査する.
- LSTとHPSによるCAFとTAMの再プログラミングを評価する.
- 細胞外マトリックス (ECM) の分解と免疫細胞の浸透への影響を評価する.
主要な成果:
- ZHL@CMは,CAFによるコラーゲン合成を抑制するためにLSTを効果的に放出します.
- 放出されたZn2+はECMを分解し,マトリックス硬さを減らし,深層の浸透を容易にする.
- HPSはTAM2を TLR4シグナル伝達を通して 炎症性フェノタイプに再プログラムします
- ZHL@CMは全身免疫活性化を誘発し,転移を抑制する.
結論:
- ZHL@CMは,HCCにおけるシネジスティック免疫調節のためのメカニズムに基づいた戦略を提供します.
- このナノディスラプタープラットフォームは 固体腫瘍における ストロマと免疫抵抗を効果的に克服します
- ダブルエンジンのアプローチは 癌の免疫療法を強化する見込みです
関連する概念動画
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


